Paradigm Strategies in Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,540
Closed -$103K 68
2021
Q2
$103K Hold
1,540
0.09% 72
2021
Q1
$97K Buy
+1,540
New +$95.8K 0.09% 70

Other funds holding BMY

Paradigm Strategies in Wealth Management's BMY Position: Q3 2021 in Review

Paradigm Strategies in Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 1,540 shares — an estimated $103K sold.

Paradigm Strategies in Wealth Management first reported a position in BMY in Q1 2021 and held it in 2 quarters. The position peaked at $103K in Q2 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • Paradigm Strategies in Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
  • Paradigm Strategies in Wealth Management sold 1,540 Bristol-Myers Squibb shares in Q3 2021, an estimated $103K.
  • Paradigm Strategies in Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2021 and held it in 2 quarters.
  • Paradigm Strategies in Wealth Management's Bristol-Myers Squibb position peaked at $103K in Q2 2021.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Paradigm Strategies in Wealth Management's 13F filing for Q3 2021, filed 15 Oct 2021.